Miyata Kazunori, Nagamoto Toshiyuki, Maruoka Shinji, Tanabe Tatsurou, Nakahara Masaaki, Amano Shiro
Meiwakai Medical Foundation, Miyata Eye Hospital, Miyakonojo, Miyazaki, Japan.
J Cataract Refract Surg. 2002 Sep;28(9):1546-50. doi: 10.1016/s0886-3350(02)01323-8.
To evaluate the efficacy and safety of the soft-shell technique in reducing corneal endothelial cell damage during cataract surgery in patients with a hard lens nucleus.
Miyata Eye Hospital, Miyakonojo, Miyazaki, Japan.
Sixty eyes of 57 cataract patients with a hard lens nucleus (Emery-Little classification grade 3 or higher) had phacoemulsification using the soft-shell technique with Healon((R)) (sodium hyaluronate 1%) and Viscoat (sodium hyaluronate 3.0%-chondroitin sulfate 4.0%) (soft-shell group) or with Healon alone (control group). The visual acuity, intraocular pressure (IOP), flare intensity in the anterior chamber, central corneal thickness, and corneal endothelial cell density were evaluated postoperatively.
There were no significant IOP elevations in either group. The mean central corneal thickness in the control group was 539 microm +/- 26.0 (SD) preoperatively and 578 +/- 52.0 microm 1 day after surgery; the increase was significant (P =.0154). There was no significant change in the central corneal thickness in the soft-shell group. There were no statistically significant differences between the 2 groups in uncorrected visual acuity, best corrected visual acuity, IOP, flare intensity in the anterior chamber, and central corneal thickness throughout the follow-up. The rate of endothelial cell loss 3 months after surgery was 6.4% +/- 9.6% in the soft-shell group and 16.3% +/- 9.8% in the control group (P =.0003).
The results suggest that the soft-shell technique is safe and effective in protecting corneal endothelial cells during cataract surgery in patients with a hard lens nucleus.
评估软壳技术在硬核白内障手术中减少角膜内皮细胞损伤的有效性和安全性。
日本宫崎县都城市宫田眼科医院。
57例患有硬核白内障(Emery-Little分级3级或更高)的患者的60只眼睛,采用含1%透明质酸钠的Healon(商品名)和含3.0%透明质酸钠-4.0%硫酸软骨素的Viscoat进行软壳技术超声乳化(软壳组),或仅使用Healon(对照组)。术后评估视力、眼压(IOP)、前房闪光强度、中央角膜厚度和角膜内皮细胞密度。
两组眼压均无显著升高。对照组术前平均中央角膜厚度为539微米±26.0(标准差),术后1天为578±52.0微米;增加显著(P = 0.0154)。软壳组中央角膜厚度无显著变化。在整个随访期间,两组在未矫正视力、最佳矫正视力、眼压、前房闪光强度和中央角膜厚度方面无统计学显著差异。术后3个月软壳组内皮细胞丢失率为6.4%±9.6%,对照组为16.3%±9.8%(P = 0.0003)。
结果表明软壳技术在硬核白内障患者白内障手术中保护角膜内皮细胞方面是安全有效的。